Atara Biotherapeutics, Inc. (ATRA) stock
Close on Nov 13, 2026Market cap $77.29MP/E –Yield –
Earnings
Atara Biotherapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Atara Biotherapeutics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 15, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 10, 2026after the close | $1.20M | -65.7% | -$0.15 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 12, 2026during market hours | $600.00K | -96.6% | -$0.32 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 16, 2026during market hours | – | – | -$0.25 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 12, 2025before the open | $3.50M | -91.3% | -$0.32 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 11, 2025during market hours | $17.60M | -38.5% | $0.19 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 15, 2025before the open | $98.10M | +258.0% | $3.50 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 7, 2025during market hours | $32.75M | +670.3% | -$1.19 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024during market hours | $40.20M | +1780.3% | -$2.93 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 12, 2024during market hours | $28.60M | +2888.5% | -$3.10 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024during market hours | $27.40M | +2134.9% | -$0.23 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 28, 2024before the open | $4.25M | +1824.0% | -$0.56 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 1, 2023before the open | $2.14M | -52.5% | -$0.66 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023during market hours | $957.00K | -98.1% | -$0.68 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 8, 2023during market hours | $1.23M | -83.2% | -$0.72 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 8, 2023during market hours | $221.00K | -97.1% | -$0.72 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 8, 2022during market hours | $4.50M | -16.7% | -$0.82 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 8, 2022during market hours | $51.60M | – | $0.18 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 5, 2022during market hours | $7.31M | – | -$0.87 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 28, 2022during market hours | $7.55M | – | -$0.96 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 4, 2021before the open | $5.40M | – | -$0.90 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 9, 2021during market hours | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 4, 2021during market hours | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 1, 2021during market hours | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 9, 2020during market hours | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 5, 2020during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period Atara Biotherapeutics guided for has been reported
Guidance history
Every forecast Atara Biotherapeutics put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 11, 2025 | operating expenses | FY2025 | +60% | Raised |
| May 15, 2025 | operating expenses | FY2025 | -65% | New |
| Nov 12, 2024 | operating expenses | FY2024 | -35% | Reaffirmed |
| Aug 12, 2024 | operating expenses | FY2024 | -35% | Reaffirmed |
| May 9, 2024 | operating expenses | FY2024 | -35% | Reaffirmed |
| Mar 28, 2024 | operating expenses | FY2024 | -35% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Atara Biotherapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- News
- Results
- News
- News
- Results
- Results
- Results
- Results
- Results
- News
- Results
- News
- Results
See a number that looks wrong?